See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $9.6B | 7.8x | 22.3x | |
| $6.8B | 23.0x | 541.1x | |
| $2.3B | 8.8x | -1131.3x | |
| $1.4B | 4.7x | -11.1x | |
| $1.2B | 21.5x | n/a | |
| $358M | 162.8x | -11.0x | |
| $310M | n/a | n/a | |
| $235M | n/a | -3.6x | |
| $180M | 3.3x | 18.2x | |
| $139M | 43.2x | -6.8x | |
| $118M | 13.4x | -5.8x | |
| $116M | 6.6x | 8.7x | |
| $81.5M | n/a | n/a | |
| $48.3M | 2.6x | 14.1x | |
| $38.6M | 13.9x | -7.4x | |
| $25.0M | 26.1x | -10.4x | |
| $2.3M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics